The role of the Tei index in assessing for cardiotoxicity from anthracycline chemotherapy: a systematic review.
Sadie BennettArzu CubukcuChun Wai WongTimothy GriffithCheryl OxleyDiane BarkerSimon DuckettDuwarakan SatchithanandaAshish PatwalaGrant HeatlieChun Shing KwokPublished in: Echo research and practice (2021)
Though there are some studies that suggest that Tei index may be a useful indicator in assessing subclinical anthracycline-related cardiotoxicity, the findings are inconsistent and so more studies are needed before the evaluation of Tei index is performed routinely in patients receiving chemotherapy.